AstraZeneca rejects Pfizer's increased offer

6 May 2014 - Deborah Wilkes

Archived

Pfizer has increased its takeover proposal for AstraZeneca, but the UK-based company has rejected the cash and shares offer worth around £63.0 billion (US$106 billion).

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: